The FDA has approved numerous new medications in 2026. Review the latest approvals through June 24, 2026, and discover why staying current is essential for medication reconciliation, survey readiness, and patient safety.
Tag: Consulting pharmacist
Drug Shortages Update: April 2026
This week we are once again providing an update on the most recent drug shortages noting 76 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Drug Shortages Update: January 2026
This week we are once again providing an update on the most recent drug shortages noting 75 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Navigating the Trypan Blue Shortage: Practical Guidance for Ophthalmology ASCs
Learn how ophthalmology ASCs can safely navigate the trypan blue shortage using pharmacist-led strategies, clinical alternatives, and conservation best practices.
The Year in Review: 2025
Another year has flown by. Unbelievably, we are quickly approaching 2026 and it’s time to look back at the biggest topics of 2025.
2025 FDA Updates on Tranexamic Acid: What Ambulatory Surgery Centers Need to Know
The FDA’s 2025 update on tranexamic acid strengthens safety warnings for IV-only use and mandates new labeling. Learn how OctariusRx helps ASCs stay compliant and enhance medication safety.
Happy National Pharmacy Week!
Happy National Pharmacy Week to all our team members and colleagues!
Drug Shortages Update: October 2025
This week we are once again providing an update on the most recent drug shortages noting 77 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
FDA requires opioid manufacturers to update prescribing information
FDA requires opioid manufacturers to update prescribing information







